3 BOOMERANG CAPITAL, LP
3 BOOMERANG CAPITAL, LP is a Series C+ and buyout fund in the US and Western Europe investing in Healthcare, biopharma-outsourcing, medical-devices, diagnostics and alternate-site-care.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, biopharma-outsourcing, medical-devices, diagnostics, alternate-site-care
- Invests in
- US-wide, Western Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2023
- Assets under management
- $546M
- Website
- 3boomerang.com
Check size not disclosed
Thesis
3 Boomerang Capital, LP is a private equity firm founded in 2023 and headquartered in Greenwich, Connecticut. The firm exclusively targets the healthcare sector, with a focus on lower middle-market companies. Their investment strategy centers on four key subsectors: Biopharma Outsourcing, Medical Device and Diagnostic Manufacturing, Information Technology and Tech-Enabled Services for healthcare, and Alternate Site Care. They seek companies with an EBITDA between $4 million and $14 million, and are open to flexible investment structures including control and minority stakes, targeting founder-owned businesses, entrepreneur-owned businesses, and corporate carve-outs. Geographically, they focus on North America and Western Europe. Their approach is hands-on and value-add, leveraging investment knowledge, strategic insights, and operational experience. They typically invest in control positions through recapitalizations, buyouts, and growth equity structures. The firm's first fund, 3 Boomerang Capital I, LP, closed in early 2024 with over $375 million in capital commitments, exceeding its $350 million target. As of December 31, 2025, the firm managed approximately $546 million in AUM.
Common questions
Does 3 BOOMERANG CAPITAL, LP invest at the Series C+ stage?
Yes. 3 BOOMERANG CAPITAL, LP lists Series C+ and buyout among the stages it invests in.
Where does 3 BOOMERANG CAPITAL, LP invest?
3 BOOMERANG CAPITAL, LP invests in the US and Western Europe.